$VIR $AVIR Greenwich, CT, based Investment company Oracle Investment Management Inc buys Vir Biotechnology Inc, Atea Pharmaceuticals Inc, Guardant Health Inc, Forian Inc, Madrigal Pharmaceuticals Inc, sells SPDR Biotech ETF, Capricor Therapeutics Inc, Motus GI Holdings Inc, Biodesix Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Oracle Investment Management Inc. As of 2021Q3, Oracle Investment Management Inc owns 40 stocks with a total value of $803 million.
VIR входит в Топ-5 бумаг этого фонда:
Vir Biotechnology Inc (VIR) - 1,181,357 shares, 6.40% of the total portfolio. Shares added by 67.45%
AVIR - новая покупка для фонда. Oracle Investment Management Inc initiated holding in Atea Pharmaceuticals Inc. The purchase prices were between $21.33 and $35.06, with an estimated average price of $27.69. The stock is now traded at around $11.360000. The impact to a portfolio due to this purchase was 1.35%. The holding were 309,126 shares as of 2021-09-30.
Нравится
Не является индивидуальной инвестиционной рекомендацией
Ваш комментарий...
Анализ компаний
Подробные обзоры финансового потенциала компаний
sergey_sergey
92 подписчика • 67 подписок
Портфель
до 500 000 ₽
Доходность
−25,69%
Еще статьи от автора
7 ноября 2022
FGEN FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.81) by 20.99 percent. This is a 281.48 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $15.73 million which missed the analyst consensus estimate of $31.59 million by 50.19 percent. This is a 89.91 percent decrease over sales of $155.97 million the same period last year.
27 октября 2022
CHMF @Foolinvest.Me как Ваше мнение по Северстали? 3 недельных зеленых свечи подряд, от дна в 560 выросла на +48%.... неужели дивы хотят заплатить?
5 октября 2022
SBER @Soul_ где шорт "зеленого" будем откупать?)